Literature DB >> 26940215

Reply to the Letter to the Editor by Sollini M et al.

F Pacini1, R Elisei2, L Fugazzola3, M Ferdeghini4, S Mariotti5, G Pellegriti6.   

Abstract

Year:  2016        PMID： 26940215     DOI： 10.1007/s40618-016-0449-1

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  3 in total

1.  A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.

Authors:  Pamela R Schroeder; Bryan R Haugen; Furio Pacini; Christoph Reiners; Martin Schlumberger; Steven I Sherman; David S Cooper; Kathryn G Schuff; Lewis E Braverman; Monica C Skarulis; Terry F Davies; Ernest L Mazzaferri; Gilbert H Daniels; Douglas S Ross; Markus Luster; Mary H Samuels; Bruce D Weintraub; E Chester Ridgway; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2006-01-04       Impact factor: 5.958

2.  Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer.

Authors:  M Sollini; C Rossetti; A Chiti
Journal:  J Endocrinol Invest       Date:  2016-03-03       Impact factor: 4.256

3.  Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients.

Authors:  Hernan P Tala Jury; Maria Grazia Castagna; Carla Fioravanti; Claudia Cipri; Ernesto Brianzoni; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2009-10-26       Impact factor: 5.958
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.